医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Blue Belt Technologies Announces the First Robotics-Assisted Partial Knee Replacement Performed in Australia Utilizing the Navio® Surgical System and the Smith & Nephew JOURNEY™ Unicompartmental Knee System

2015年12月22日 AM07:00
このエントリーをはてなブックマークに追加


 

MINNEAPOLIS

Blue Belt Technologies, a medical technology company specializing in robotic solutions for orthopedic surgery, announced the first Navio-assisted surgery performed in Australia utilizing the Smith & Nephew JOURNEY Uni Knee System. The procedure was performed by Dr. Tony Spriggins, Orthopedic Surgeon at SPORTSMED·SA in Adelaide, Australia.

“The final result today was a well aligned implant with great ligament balance post operatively,” said Dr. Spriggins. “I’m really happy with the way our first Navio case has gone and look forward to seeing the long term clinical result.”

The Navio® system provides robotic assistance for partial knee replacement procedures through CT-free navigation software and a unique computer controlled, bone shaping tool. In a procedure that is technically demanding, Navio enables surgeons to remove the damaged surfaces of the patient’s knee, balance their joint, and position the implant with great precision.

“A select cohort of patients have great outcomes in partial knees, but the key is perfect alignment and balance,” said Dr. Spriggins. “Paired with a quality implant like the JOURNEY Uni, the Navio system helps us achieve this through advanced computer navigation and robotics.”

The JOURNEY Uni knee, made by Smith & Nephew, is a ligament-preserving partial knee implant made from the company’s unique, wear-reducing OXINIUM™ material.

The expansion of Navio-assisted procedures into Australia provides orthopedic surgeons with the only CT-free robotics-assisted solution for partial knee replacement.

Blue Belt Technologies, Inc.

Blue Belt Technologies is a global leader in surgical robotics, developing and commercializing next-generation robotics-assisted technologies for use in orthopedic surgery and other specialties. Blue Belt is focused on the continued commercial success and application expansion of the Navio® Surgical System, which leverages the company’s proprietary and differentiated Precision Freehand Sculpting™ technology. The Navio system helps surgeons deliver precise and consistent results for their patients. For more information visit www.bluebelttech.com.

JOURNEY and OXINIUM are trademarks of Smith & Nephew.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151221005871/en/

CONTACT

Blue Belt Technologies, Inc.
Adam Simone, +1-763-452-4917
asimone@bluebelttech.com
www.BlueBeltTech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田获得CHMP肯定意见,接纳ADCETRIS® (brentuximab vedotin)联合AVD用于治疗既往未曾治疗的CD30+ IV期霍奇金淋巴瘤成人患者
  • 富士制药向Alvotech投资5000万美元
  • 武田薬品、未治療のCD30陽性ステージ4ホジキンリンパ腫成人患者を治療するためのアドセトリス(ブレンツキシマブ・ベドチン)とAVDの併用に関するCHMPの肯定的見解を受領
  • AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax Credit
  • Aptorum Group [APM] to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO Closing